Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prothena Corp Public (PRTA) Invested Capital (2016 - 2025)

Historic Invested Capital for Prothena Corp Public (PRTA) over the last 14 years, with Q3 2025 value amounting to $295.0 million.

  • Prothena Corp Public's Invested Capital fell 4479.6% to $295.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $295.0 million, marking a year-over-year decrease of 4479.6%. This contributed to the annual value of $486.9 million for FY2024, which is 1326.04% down from last year.
  • Prothena Corp Public's Invested Capital amounted to $295.0 million in Q3 2025, which was down 4479.6% from $324.3 million recorded in Q2 2025.
  • Over the past 5 years, Prothena Corp Public's Invested Capital peaked at $622.0 million during Q4 2022, and registered a low of $234.6 million during Q1 2021.
  • For the 5-year period, Prothena Corp Public's Invested Capital averaged around $467.5 million, with its median value being $486.9 million (2024).
  • In the last 5 years, Prothena Corp Public's Invested Capital surged by 15327.54% in 2021 and then plummeted by 4479.6% in 2025.
  • Over the past 5 years, Prothena Corp Public's Invested Capital (Quarter) stood at $466.0 million in 2021, then soared by 33.47% to $622.0 million in 2022, then dropped by 9.75% to $561.4 million in 2023, then decreased by 13.26% to $486.9 million in 2024, then plummeted by 39.42% to $295.0 million in 2025.
  • Its Invested Capital was $295.0 million in Q3 2025, compared to $324.3 million in Q2 2025 and $437.7 million in Q1 2025.